Crosstalk between ERα and Receptor Tyrosine Kinase Signalling and Implications for the Development of Anti-Endocrine Resistance

Although anti-endocrine therapies have significantly advanced the treatment of breast cancer, they pose the problem of acquired drug resistance. The oestrogen receptor (ER)-expressing breast cancer cell lines MCF-7 and T47D alongside their in vitro derived resistant counterparts MCF-7-TR (tamoxifen-...

Descripción completa

Detalles Bibliográficos
Autores principales: Montaser, Rugaia Z., Coley, Helen M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6025235/
https://www.ncbi.nlm.nih.gov/pubmed/29925812
http://dx.doi.org/10.3390/cancers10060209

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6025235/
https://www.ncbi.nlm.nih.gov/pubmed/29925812
http://dx.doi.org/10.3390/cancers10060209

Ejemplares similares